Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Romania- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Romania176 clinical trials in Brasov, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
Romania
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on meningococcal infection prevention and respiratory syncytial virus (RSV) in infants, testing novel vaccines and preventive treatments.
Research emphasizes safety and efficacy in pediatric populations.
Innovative research targeting heart failure prevention and hypertriglyceridemia, exploring new therapeutic approaches.
Studies focus on both prevention and treatment strategies.
Comprehensive trials investigating treatments for Myasthenia Gravis, Sjögren's Syndrome, and other autoimmune disorders.
Research aims to improve daily living activities and symptom management.
Advanced research in asthma and chronic rhinosinusitis, evaluating innovative treatments and therapeutic approaches.
Focus on uncontrolled conditions and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.